Hepatology

In Spain, HCV prevalence among people experiencing homelessness has declined significantly, from 7.2% in 2019 to 3.4% in 2023.

A new study examined the influence of clinical and histologic risk factors on long-term MASLD outcomes in patients confirmed via liver biopsy.

Rates of liver-related mortality (LRM) in the USA surged by 19.1% from 2018 to 2021, with substantial state-by-state differences…

A newly developed prognostic model predicts liver cancer risk in patients with hepatitis B without cirrhosis, identifying a nonlinear relationship between viral load and cancer risk

Researchers have revealed that a previous paternal hepatitis B virus infection before conception is associated with an increased risk of congenital heart diseases in offspring.

The Baveno VI criteria, combining liver stiffness and platelet count, offer a noninvasive, cost-effective approach to identifying high-risk varices in patients with cirrhosis

The latest clinical guidelines for diagnosing and managing metabolic dysfunction-associated steatotic liver disease, previously known as NAFLD

A novel automated speech analysis platform has been developed to test for minimal hepatic encephalopathy (HE) and to predict overt HE in patients with cirrhosis.